Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Times to endovascular treatment following two triage models.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 13, 2022
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant.
Journal: Open forum infectious diseases
Published: September 05, 2017
Postural lung recruitment assessed by lung ultrasound in mechanically ventilated children.
Journal: Critical ultrasound journal
Published: July 27, 2017
Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics.
Journal: Open forum infectious diseases
Published: January 04, 2016
Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
Journal: Enfermedades infecciosas y microbiologia clinica
Published: December 18, 2015
Monotherapy with darunavir/ritonavir is effective and safe in clinical practice.
Journal: Journal of the International AIDS Society
Published: November 15, 2014
Should screening for Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-men who have sex with men be recommended?
Journal: Journal of the International AIDS Society
Published: November 15, 2014
Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection.
Journal: Antiviral therapy
Published: November 11, 2014
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
Journal: Hepatology (Baltimore, Md.)
Published: July 26, 2014
Serum ferritin in HIV-positive patients is related to immune deficiency and inflammatory activity.
Journal: International journal of STD & AIDS
Published: March 22, 2014
A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 26, 2013
Last Updated: 09/26/2026